|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:434-435
© 2008 The American Association for Thoracic Surgery
Brief Communication |
a AP-HP, Assistance Publique—Hôpitaux de Paris, Hôpital Européen Georges Pompidou Service de Chirurgie Cardiovasculaire, Paris, France
b Université René Descartes, Paris, France
Received for publication June 29, 2007; accepted for publication August 7, 2007. * Address for reprints: Rachid Zegdi, MD, PhD, Hôpital Européen Georges Pompidou, Service de Chirurgie Cardiovasculaire, 20, rue Leblanc, 75908 Paris, France. (Email: rzegdi{at}hotmail.com).
Mechanical circulatory support for pheochromocytoma-induced cardiomyopathy has been reported rarely.1
We describe the case of a patient with an atypical form of pheochromocytoma-induced cardiogenic shock who was successfully managed with extracorporeal life support (ECLS).
A 51-year-old woman with a medical history suggestive of Crohn disease and newly diagnosed hypertension had acute respiratory failure 2 hours after mastectomy for breast cancer. Clinically, the patient harbored pulmonary edema, tachycardia, and high blood pressure. Electrocardiography revealed ST-segment depression in inferior and lateral leads, and initial troponin I blood level was increased to 3 µg/L.
On admission to the intensive care unit, the patient had cardiogenic shock with metabolic acidosis (pH = 7.14), acute renal failure (creatinine level = 184 µmol/L), and increased troponin I level (27 µg/L; reference range < 0.1 µg/L). Echocardiography revealed severe global left ventricular hypokinesia (ejection fraction [EF] < 30%) with no pericardial effusion. Severe cardiorespiratory failure necessitated tracheal intubation and mechanical ventilation. Emergency coronary angiogram was performed to assess the integrity of the coronary vascular bed. On the way to the catheterization laboratory, cardiac arrest occurred owing to electromechanical dissociation. The patient recovered rapidly with intravenous administration of epinephrine. A coronary angiogram revealed fully patent coronary arteries (
Figure 1). However, ventriculography showed dilation and akinesis of the basal and midventricular segments of the heart, whereas the apex was hyperkinetic (Video 1). Global left ventricular EF was less than 30%.
|
The clinical status improved drastically with circulatory assistance. On day 0, EF was less than 5% and increased to 50% on day 5 (
Figure 2). ECLS was removed the day after. On day 7, EF was 72% without any inotropic support. Hemodynamic improvement was paralleled by regression of the pulmonary edema and the acute renal failure, allowing extubation on day 8.
|
Takotsubo cardiomyopathy syndrome is being more frequently recognized.2
It affects mainly women in the postmenopausal period. It consists in an acute coronary syndrome with angiographically normal coronary vessels and reversible left ventricular wall motion abnormalities. Typically, the left ventricular apex is dyskinetic (apical ballooning) whereas the basal portion is hyperkinetic. However, variant forms sparing the apex have been recently reported.3
The cardiac surgeon is faced with Takotsubo cardiomyopathy or its variants mainly when cardiogenic shock develops in these settings. Incidence of cardiogenic shock after Takotsubo cardiomyopathy reached 15% in a recent large series.4
Anecdotal descriptions of left ventricular apical rupture or thrombosis in this syndrome were also reported.2
Besides inotropic support, circulatory assistance may be required as in the present case. Reversibility is a major characteristic of this syndrome. Left ventricular recovery, within a week, was particularly impressive in our patient. Takotsubo cardiomyopathy seems to have a better prognosis than myocardial infarction and does not usually recur.2
Another major point in the care of patients with Takotsubo cardiomyopathy is the search for a curable cause. Usually, the syndrome is "idiopathic," and a precipitating factor (an emotional or a physical stress) can be often individualized. Exceptional cases of pheochromocytoma-induced Takotsubo cardiomyopathy have been reported,5
but the pathogenesis of the syndrome is unknown, albeit this association favors a cardiotoxic effect of catecholamines.
In conclusion, cardiac surgeons should be aware of this recently recognized syndrome and particularly of its reversal, even in the most clinically severe forms, as reported here.
Supplementary data
Supplementary data
Supplementary data associated with this article can be found in the online version, at doi:10.1016/j.jtcvs.2007.08.068
References
Related Article
This article has been cited by other articles:
![]() |
E. A. Hessel II and M. J. London Takotsubo (Stress) Cardiomyopathy and the Anesthesiologist: Enough Case Reports. Let's Try to Answer Some Specific Questions! Anesth. Analg., March 1, 2010; 110(3): 674 - 679. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |